These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2809689)

  • 21. Comparison of the in vitro activities of ofloxacin and tetracycline against Chlamydia trachomatis as assessed by indirect immunofluorescence.
    Bailey JM; Heppleston C; Richmond SJ
    Antimicrob Agents Chemother; 1984 Jul; 26(1):13-6. PubMed ID: 6383207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial activity of U-70138F (paldimycin), roxithromycin (RU 965), and ofloxacin (ORF 18489) against Chlamydia trachomatis in cell culture.
    Stamm WE; Suchland R
    Antimicrob Agents Chemother; 1986 Nov; 30(5):806-7. PubMed ID: 3467650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K.
    Donati M; Di Francesco A; D'Antuono A; Delucca F; Shurdhi A; Moroni A; Baldelli R; Cevenini R
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5379-80. PubMed ID: 20855744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antichlamydial activity of ofloxacin.
    Hirai K; Une T
    Microbiol Immunol; 1986; 30(5):445-50. PubMed ID: 3462450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy of ofloxacin in sexually transmitted male urethritis and cervicitis].
    Kumamoto Y; Sakai S; Hirose T; Tsunekawa T; Machida T; Kiyota H; Okazaki T; Kishi H; Higashihara E; Aso Y
    Jpn J Antibiot; 1988 Oct; 41(10):1445-79. PubMed ID: 3144614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro effects of spectinomycin and ceftriaxone alone or in combination with other antibiotics against Chlamydia trachomatis.
    Shang S; Xia L; Zhong M; Zhang J; Zhao J; Gong X; Mabey D; Wang Q
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1584-6. PubMed ID: 15793145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of the in vitro susceptibility of clinical isolates of chlamydia trachomatis with serovar and duration of antibiotic exposure.
    Zheng H; Xue Y; Bai S; Qin X; Lu P; Yang B
    Sex Transm Dis; 2015 Mar; 42(3):115-9. PubMed ID: 25668641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective randomized trial of ofloxacin vs. doxycycline in the treatment of uncomplicated male urethritis.
    Boslego JW; Hicks CB; Greenup R; Thomas RJ; Wiener HA; Ciak J; Tramont EC
    Sex Transm Dis; 1988; 15(4):186-91. PubMed ID: 3147522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Susceptibility study on urogenital Chlamydia trachomatis to 19 kinds of antibiotics].
    Bai H; Dong J; Ning B
    Zhonghua Yi Xue Za Zhi; 1995 Jan; 75(1):11-4, 60. PubMed ID: 7600311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bacteriostatic and bactericidal activities of cyclines, macrolides and fluoroquinolones against Chlamydia trachomatis].
    Dailloux M; Villemain P
    Pathol Biol (Paris); 1992 May; 40(5):455-60. PubMed ID: 1495827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of quinolones in chlamydial infection.
    Oriel JD
    Rev Infect Dis; 1989; 11 Suppl 5():S1273-6. PubMed ID: 2672254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The comparative in-vitro activity of ofloxacin.
    Grüneberg RN; Felmingham D; O'Hare MD; Robbins MJ; Perry K; Wall RA; Ridgway GL
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():9-19. PubMed ID: 3182468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of ofloxacin against Chlamydia trachomatis.
    Møller BR; Evans R; Kaspersen P; From E
    Drugs; 1987; 34 Suppl 1():181-3. PubMed ID: 3481321
    [No Abstract]   [Full Text] [Related]  

  • 34. Ofloxacin: therapeutic results in Chlamydia trachomatis urethritis.
    Bischoff W
    Infection; 1986; 14 Suppl 4():S316-7. PubMed ID: 3546156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative in vitro activity of a new macrolide RU 28965 and of erythromycin against Chlamydia trachomatis].
    Dutilh B; de Barbeyrac B; Lafferrière C; Bébéar C
    Pathol Biol (Paris); 1986 May; 34(5):445-7. PubMed ID: 3534718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimum inhibitory and minimal lethal concentration against Chlamydia trachomatis dependent on the time of addition and the duration of the presence of antibiotics.
    Notomi T; Ikeda Y; Nagayama A
    Chemotherapy; 1999; 45(4):242-8. PubMed ID: 10394006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ofloxacin treatment of nongonococcal urethritis. A multi-center study in Asia.
    Kawada Y; Lee JM; Saito I; Lai C; Chang LS; Limson BM; Polnikorn N; Daili SF
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):190-2. PubMed ID: 2185760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility of Chlamydia trachomatis to antibiotics in vitro and in vivo.
    Johannisson G; Sernryd A; Lycke E
    Sex Transm Dis; 1979; 6(2):50-7. PubMed ID: 494040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial susceptibilities of Chlamydia trachomatis isolated from the urethra and pharynx of Japanese males.
    Kai S; Wada K; Sadahira T; Araki M; Ishii A; Watanabe T; Monden K; Uno S; Araki T; Nasu Y
    J Infect Chemother; 2017 Aug; 23(8):512-516. PubMed ID: 28476331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of in vitro activity of rokitamycin against Chlamydia trachomatis].
    Bannai H; Miyano A; Miyazawa H; Ashihara Y
    Kansenshogaku Zasshi; 1990 Jun; 64(6):687-92. PubMed ID: 2401815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.